{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:49:59Z","timestamp":1785235799115,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T00:00:00Z","timestamp":1458259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T00:00:00Z","timestamp":1458259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/gt.2016.30","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T21:52:06Z","timestamp":1458337926000},"page":"580-591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Adenoviral vector encoding soluble Flt-1 engineered human endometrial mesenchymal stem cells effectively regress endometriotic lesions in NOD\/SCID mice"],"prefix":"10.1038","volume":"23","author":[{"given":"A R","family":"Koippallil Gopalakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M","family":"Metkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Warty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,18]]},"reference":[{"key":"BFgt201630_CR1","first-page":"155","volume":"13","author":"S Esmaeilzadeh","year":"2015","unstructured":"Esmaeilzadeh S, Mirabi P, Basirat Z, Zeinalzadeh M, Khafri S . Association between endometriosis and hyperprolactinemia in infertile women. Iran J Reprod Med 2015; 13: 155\u2013160.","journal-title":"Iran J Reprod Med"},{"key":"BFgt201630_CR2","first-page":"1","volume":"28","author":"A Capobianco","year":"2013","unstructured":"Capobianco A, Rovere-Querini P . Endometriosis, a disease of the macrophage. Front Immunol 2013; 28: 1\u201314.","journal-title":"Front Immunol"},{"key":"BFgt201630_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/GCO.0000000000000084","volume":"26","author":"L Platteeuw","year":"2014","unstructured":"Platteeuw L, D'Hooghe T . Novel agents for the medical treatment of endometriosis. Curr Opin Obstet Gynecol 2014; 26: 243\u2013252.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"BFgt201630_CR4","doi-asserted-by":"publisher","first-page":"179515","DOI":"10.1155\/2014\/179515","volume":"2014","author":"S Sourial","year":"2014","unstructured":"Sourial S, Tempest N, Hapangama DK . Theories on the pathogenesis of endometriosis. Int J Reprod Med 2014; 2014: 179515.","journal-title":"Int J Reprod Med"},{"key":"BFgt201630_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.20344\/amp.5244","volume":"27","author":"D Djokovic","year":"2014","unstructured":"Djokovic D, Calhaz-Jorge C . Angiogenesis as a therapeutic target in endometriosis. Acta Med Port 2014; 27: 489\u2013497.","journal-title":"Acta Med Port"},{"key":"BFgt201630_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s11596-009-0520-7","volume":"29","author":"H Wang","year":"2009","unstructured":"Wang H, Gorpudolo N, Li Y, Feng D, Wang Z, Zhang Y . Elevated vascular endothelial growth factor-A in the serum and peritoneal fluid of patients with endometriosis. J Huazhong Univ Sci Technolog Med Sci 2009; 29: 637\u2013641.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"BFgt201630_CR7","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.4238\/2013.April.2.20","volume":"2","author":"YZ Li","year":"2013","unstructured":"Li YZ, Wang LJ, Li X, Li SL, Wang JL, Wu ZH et al. Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis: an updated systematic review and meta-analysis of 14 case-control studies. Genet Mol Res 2013; 2: 1035\u20131044.","journal-title":"Genet Mol Res"},{"key":"BFgt201630_CR8","first-page":"179","volume":"47","author":"Y Jiang","year":"2012","unstructured":"Jiang Y, Tang JY, Wu Y, Zhao TF . Vascular endothelial growth factor gene polymorphisms and the risk of endometriosis: a systematic review. Zhonghua Fu Chan Ke Za Zhi 2012; 47: 179\u2013184.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"BFgt201630_CR9","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0049-3848(15)50439-8","volume":"Suppl 1","author":"J Mar\u00ed-Alexandre","year":"2015","unstructured":"Mar\u00ed-Alexandre J, Garc\u00eda-Oms J, Barcel\u00f3-Molina M, Gilabert-Aguilar J, Estell\u00e9s A, Braza Boils A et al. microRNAs and angiogenesis in endometriosis. Thromb Res 2015; Suppl 1: S38\u2013S40.","journal-title":"Thromb Res"},{"key":"BFgt201630_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/intimm\/dxu103","volume":"27","author":"AR Koippallil Gopalakrishnan Nair","year":"2015","unstructured":"Koippallil Gopalakrishnan Nair AR, Pandit H, Warty N, Madan T . Endometriotic mesenchymal stem cells exhibit a distinct immune phenotype. Int Immunol 2015; 27: 195\u2013204.","journal-title":"Int Immunol"},{"key":"BFgt201630_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj.bjp.0706860","volume":"149","author":"S Ferrero","year":"2006","unstructured":"Ferrero S, Ragni N, Remorgida V . Antiangiogenic therapies in endometriosis. Br J Pharmacol 2006; 149: 133\u2013135.","journal-title":"Br J Pharmacol"},{"key":"BFgt201630_CR12","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1210\/jc.2003-031406","volume":"89","author":"AW Nap","year":"2004","unstructured":"Nap AW, Griffioen AW, Dunselman GA, Bouma-Ter Steege JC, Thijssen VL, Evers JL et al. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 2004; 89: 1089\u20131095.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFgt201630_CR13","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.fertnstert.2011.07.008","volume":"96","author":"H Xu","year":"2011","unstructured":"Xu H, Becker CM, Lui WT, Chu CY, Davis TN, Kung AL et al. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C\/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. Fertil Steril 2011; 96: 1021\u20131028.","journal-title":"Fertil Steril"},{"key":"BFgt201630_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/jb\/mvs136","volume":"153","author":"M Shibuya","year":"2013","unstructured":"Shibuya M . Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem 2013; 153: 13\u201319.","journal-title":"J Biochem"},{"key":"BFgt201630_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/sj.gt.3301680","volume":"9","author":"JWB Bainbridge","year":"2002","unstructured":"Bainbridge JWB, Mistry A, De Alwis M, Paleolog E, Baker A, Thrasher AJ et al. Inhibition of retinal neovascularization by gene transfer of soluble VEGF receptor sFlt-1. Gene Therapy 2002; 9: 320\u2013326.","journal-title":"Gene Therapy"},{"key":"BFgt201630_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/humupd\/dmq009","volume":"16","author":"KE May","year":"2010","unstructured":"May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH, Becker CM . Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update 2010; 16: 651\u2013674.","journal-title":"Hum Reprod Update"},{"key":"BFgt201630_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/hum.2009.153","volume":"21","author":"T Igarashi","year":"2010","unstructured":"Igarashi T, Miyake K, Masuda I, Takahashi H, Shimada T . Adeno-associated vector (type 8)-mediated expression of soluble Flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model. Hum Gene Ther 2010; 21: 631\u2013637.","journal-title":"Hum Gene Ther"},{"key":"BFgt201630_CR18","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/ijc.27495","volume":"131","author":"M Sopo","year":"2012","unstructured":"Sopo M, Anttila M, Sallinen H, Tuppurainen L, Laurema A, Laidinen S et al. Antiangiogenic gene therapy with soluble VEGF-receptors -1, -2 and -3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma. Int J Cancer 2012; 131: 2394\u20132401.","journal-title":"Int J Cancer"},{"key":"BFgt201630_CR19","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/1471-2407-8-306","volume":"8","author":"M Hu","year":"2008","unstructured":"Hu M, Yang JL, Teng H, Jia YQ, Wang R, Zhang XW et al. Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sflt-1 in mouse tumor model. BMC Cancer 2008; 8: 306\u2013316.","journal-title":"BMC Cancer"},{"key":"BFgt201630_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ymthe.2005.04.022","volume":"12","author":"CM Lai","year":"2005","unstructured":"Lai CM, Shen WY, Brankov M, Lai YK, Barnett NL, Lee SY et al. Long-term evaluation of AAV-mediated sflt-1 gene therapy for ocular neovascularization in mice and monkeys. Mol Ther 2005; 12: 659\u2013668.","journal-title":"Mol Ther"},{"key":"BFgt201630_CR21","first-page":"2057","volume":"7","author":"PJ Mahasreshti","year":"2001","unstructured":"Mahasreshti PJ, Navarro JG, Kataram M, Wang MH, Carey D, Siegal GP et al. Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma. Clin Cancer Res 2001; 7: 2057\u20132066.","journal-title":"Clin Cancer Res"},{"key":"BFgt201630_CR22","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1097\/01.ju.0000117801.04926.a8","volume":"171","author":"I Yoshimura","year":"2004","unstructured":"Yoshimura I, Mizuguchi Y, Miyajima A, Asano T, Tadakuma T, Hayakawa M . Suppression of lung metastasis of renal cell carcinoma by the intramuscular gene transfer of a soluble form of vascular endothelial growth factor receptor. I J Urol 2004; 171: 2467\u20132470.","journal-title":"I J Urol"},{"key":"BFgt201630_CR23","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/sj.gt.3302104","volume":"10","author":"AO Afuwape","year":"2003","unstructured":"Afuwape AO, Feldman M, Paleolog EM . Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis. Gene Therapy 2003; 10: 1950\u20131960.","journal-title":"Gene Therapy"},{"key":"BFgt201630_CR24","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1089\/10430340260185102","volume":"13","author":"M Mae","year":"2002","unstructured":"Mae M, Crystal RG . Gene transfer to the pleural mesothelium as a strategy to deliver proteins to the lung parenchyma. Hum Gene Ther 2002; 13: 1471\u20131482.","journal-title":"Hum Gene Ther"},{"key":"BFgt201630_CR25","first-page":"2701","volume":"9","author":"PJ Mahasreshti","year":"2003","unstructured":"Mahasreshti PJ, Kataram M, Wang MH, Stockard CR, Grizzle WE, Carey D et al. Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity. Clin Cancer Res 2003; 9: 2701\u20132710.","journal-title":"Clin Cancer Res"},{"key":"BFgt201630_CR26","first-page":"1046","volume":"15","author":"JS Park","year":"2015","unstructured":"Park JS, Suryaprakash S, Lao YH, Leong KW . Engineering mesenchymal stem cells for regenerative medicine and drug delivery. Methods 2015; 15: 1046\u20132023.","journal-title":"Methods"},{"key":"BFgt201630_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2174\/1574888X09666140923101110","volume":"9","author":"T Tanna","year":"2014","unstructured":"Tanna T, Sachan V . Mesenchymal stem cells: potential in treatment of neurodegenerative diseases. Curr Stem Cell Res Ther 2014; 9: 513\u2013521.","journal-title":"Curr Stem Cell Res Ther"},{"key":"BFgt201630_CR28","first-page":"3853","volume":"7","author":"J Yang","year":"2014","unstructured":"Yang J, Huang F . Stem cell and endometriosis: new knowledge may be producing novel therapies. Int J Clin Exp Med 2014; 7: 3853\u20133858.","journal-title":"Int J Clin Exp Med"},{"key":"BFgt201630_CR29","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.fertnstert.2010.09.064","volume":"15","author":"AP Kao","year":"2011","unstructured":"Kao AP, Wang KH, Chang CC, Lee JN, Long CY, Chen HS et al. Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model. Fertil Steril 2011; 15: 1308\u20131315.","journal-title":"Fertil Steril"},{"key":"BFgt201630_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1196\/annals.1434.014","volume":"1127","author":"IE Sasson","year":"2008","unstructured":"Sasson IE, Taylor HS . Stem cells and the pathogenesis of endometriosis. Ann NY Acad Sci 2008; 1127: 106\u2013115.","journal-title":"Ann NY Acad Sci"},{"key":"BFgt201630_CR31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/humupd\/dms026","volume":"18","author":"MW Laschke","year":"2012","unstructured":"Laschke MW, Menger MD . Anti-angiogenic treatment strategies for the therapy of endometriosis. Hum Reprod Update 2012; 18: 682\u2013702.","journal-title":"Hum Reprod Update"},{"key":"BFgt201630_CR32","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1210\/jc.2002-021912","volume":"88","author":"ML Hull","year":"2003","unstructured":"Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, Tom BD et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 2003; 88: 2889\u20132899.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFgt201630_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cellimm.2014.12.003","volume":"293","author":"A Amari","year":"2015","unstructured":"Amari A, Ebtekar M, Moazzeni SM, Soleimani M, Amirabad LM, Tahoori MT et al. Investigation of immunomodulatory properties of human Wharton's Jelly-derived mesenchymal stem cells after lentiviral transduction. Cell Immunol 2015; 293: 59\u201366.","journal-title":"Cell Immunol"},{"key":"BFgt201630_CR34","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/mt.2009.30","volume":"17","author":"CK Chuang","year":"2009","unstructured":"Chuang CK, Wong TH, Hwang SM, Chang YH, Chen GY, Chiu YC et al. Baculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. Mol Ther 2009; 17: 889\u2013896.","journal-title":"Mol Ther"},{"key":"BFgt201630_CR35","doi-asserted-by":"crossref","unstructured":"Lee S, Choi E, Cha MJ, Hwang KC . Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy. Oxid Med Cell Longev 2015 2015: 632902.","DOI":"10.1155\/2015\/632902"},{"key":"BFgt201630_CR36","doi-asserted-by":"publisher","first-page":"732742","DOI":"10.1155\/2013\/732742","volume":"2013","author":"TJ Kean","year":"2013","unstructured":"Kean TJ, Lin P, Caplan AI, Dennis JE . MSCs: delivery routes and engraftment, cell-targeting strategies, and immune modulation. Stem Cells Int 2013; 2013: 732742.","journal-title":"Stem Cells Int"},{"key":"BFgt201630_CR37","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1038\/emm.2013.94","volume":"15","author":"MB Murphy","year":"2013","unstructured":"Murphy MB, Moncivais K, Caplan AI . Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 2013; 15: 45 e54.","journal-title":"Exp Mol Med"},{"key":"BFgt201630_CR38","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/j.1447-0756.2010.01345.x","volume":"36","author":"B Liu","year":"2010","unstructured":"Liu B, Wang NN, Wang ZL, Hong SS, Li JT, Ding HJ et al. Improved nude mouse models for green fluorescence human endometriosis. J Obstet Gynaecol Res 2010; 36: 1214\u20131221.","journal-title":"J Obstet Gynaecol Res"},{"key":"BFgt201630_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3892\/etm.2013.1458","volume":"7","author":"DP Yuan","year":"2014","unstructured":"Yuan DP, Gu L, Long J, Chen J, Ni J, Qian N et al. Shikonin reduces endometriosis by inhibiting RANTES secretion and mononuclear macrophage chemotaxis. Exp Ther Med 2014; 7: 685\u2013690.","journal-title":"Exp Ther Med"},{"key":"BFgt201630_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1055\/s-2003-41322","volume":"21","author":"KG Osteen","year":"2003","unstructured":"Osteen KG, Yeaman GR, Bruner-Tran KL . Matrix metalloproteinases and endometriosis. Semin Reprod Med 2003; 21: 155\u2013164.","journal-title":"Semin Reprod Med"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201630.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201630","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201630.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T13:14:35Z","timestamp":1648559675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,18]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["BFgt201630"],"URL":"https:\/\/doi.org\/10.1038\/gt.2016.30","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,18]]},"assertion":[{"value":"22 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}